Before You Turn a Health Study Into a Headline, Ask These 8 Questions
Eight practical checks for turning new health research into accessible content without making the findings sound stronger than they are.
A new study lands in your inbox. It covers a topic your audience already cares about. The abstract reports a statistically significant result. The headline almost writes itself.
Imagine a randomized study of a wearable-guided recovery programme that reports improvements in heart rate variability (HRV) and self-reported sleep quality.
A possible headline:
“New Study Shows Wearable Protocol Improves Stress Resilience and Recovery.” Would it work? Let’s see.
On the one hand, the headline sounds reasonable. But did researchers actually measure stress resilience? How large were the improvements? Who participated? And does one study give us enough confidence to write about the result this strongly?
This is where research writing becomes more than summarizing a paper. Good health content should simplify the findings. Readers don’t need a methods section in every article, newsletter or social post.
The skill is knowing what can be simplified without changing the conclusion because a few ordinary-looking edits can do exactly that:
“Studied clinically” → “clinically proven”
“Associated with better sleep” → “improves sleep”
“Supports relaxation” → “treats anxiety”
In the U.S., for example, those distinctions can matter beyond editorial quality. Health claims can create regulatory risk when the overall impression goes further than the available substantiation. And for some products, moving from general wellness language toward claims about diagnosing, treating, mitigating, curing or preventing disease can change the regulatory context.
A wording change that looks like ordinary copyediting can therefore change not only what readers understand, but the kind of claim a company may need to substantiate.
The point isn’t to make health content timid. It is to know how strong the evidence is before deciding how strong the story should be.
One thing before we begin:
Don’t evaluate a study from a press release, company announcement or another article about it. Those are useful for finding research. To evaluate it, open the paper.
Then ask these eight questions.
1. What kind of study are you looking at?
Before asking whether the result is impressive, ask what kind of question the study design can answer.
Suppose researchers find that people who regularly use a sleep supplement report better sleep than people who don’t. That association may be real. But perhaps supplement users also exercise more, drink less alcohol or have other habits that contribute to better sleep.
An observational study can show that two things are related. It cannot, by itself, establish that the supplement caused the difference.
A randomized controlled trial can usually give us more confidence about cause and effect because participants are assigned to different groups. But “randomized” isn’t a quality guarantee. How the study was conducted still matters.
Our fictional wearable study is randomized. Good. That gives us more confidence in the comparison. But our proposed headline says the programme “improves stress resilience.” Study design alone isn’t enough to justify that conclusion. We still need to know what researchers actually measured.
Editorial check: Does the verb in your headline claim more certainty than the study design supports?
“Associated with” does not automatically become “improves.” And “researchers observed” does not automatically become “researchers proved.”
2. Who was actually studied?
Suppose our wearable trial included 72 healthy adults aged 25–40 who already used wearable technology regularly. That doesn’t make it a weak study. It tells us where its findings apply most directly.
A small study can answer a narrow physiological question well while providing poor support for a sweeping population claim. And the number of participants is only part of the picture. Who were they?
Check their age, health status, relevant inclusion and exclusion criteria, how they were recruited and whether they resemble the population your article is talking about.
Results in healthy adults don’t automatically tell us what would happen in people with insomnia or anxiety. Experienced wearable users may respond differently from people unfamiliar with the technology.
Researchers call this generalizability. For an editor, the question is simpler.
Editorial check: Does your content describe the people who were studied—or the people you want the finding to apply to?
You can explain why a study is relevant to your audience without quietly rewriting the study population to make it relevant.
3. What did the researchers actually measure?
Our wearable study reports improvements in Heart rate variability (HRV) and self-reported sleep quality. Our headline says: “Improves Stress Resilience and Recovery.” Where did “stress resilience” come from?
HRV can provide useful information about autonomic nervous system activity and is often studied in relation to stress and recovery. But a change in HRV does not automatically demonstrate that participants became more resilient to stress.
This happens frequently in health and wellness research.
A study might measure glucose variability rather than whether people develop diabetes. It might measure an inflammatory marker rather than long-term health. A longevity study might report a change in a biological-age marker without showing that anyone will actually live longer.
Those measures can be valuable. The problem starts when the interpretation becomes the outcome.
This is where concepts such as proxy measures and, in some research contexts, surrogate endpoints become relevant. A study may measure something that provides information about a broader outcome without directly measuring that outcome itself.
Editorial check: Did researchers measure the benefit in your headline—or are you inferring it from something they measured?
Sometimes the measured outcome is the better story. Instead of turning HRV into “stress resilience,” explain what happened to HRV and what that may—and may not—tell us.
4. Was the result statistically significant—and was it large enough to matter?
You reach the results section and find: “The difference was statistically significant.” Useful information. But it doesn’t tell you, by itself, whether the difference was large or meaningful.
Imagine a large sleep study finds that participants using an intervention slept four minutes longer per night than the comparison group. With enough participants, that difference could be statistically significant.
Now compare:
“Study finds statistically significant improvement in sleep duration.”
with:
“Participants slept four minutes longer per night on average.”
Both may describe the same result. But in everyday language, “significant” often means important or substantial. That’s why finding p < 0.05 shouldn’t end your fact-check.
Look at the actual difference. Where reported, examine the effect size and confidence interval too: how large does the effect appear to be, and how precise is that estimate?
Then ask the question your reader probably cares about:
Would a difference of this size actually matter?
In some clinical research, an established minimal clinically important difference can help answer that. Not every wellness outcome has one, so don’t invent a threshold where none exists.
Editorial check: Was the result statistically significant? How large was the effect? And is that difference large enough to matter in practice?
“Statistically significant” can tell you a result deserves attention. It cannot tell you, by itself, how much attention your headline should give it.
5. What was the intervention compared with?
Suppose sleep scores improved by 15% in our wearable group. Sounds impressive. But what if they improved by 13% in the comparison group?
The 15% figure hasn’t become inaccurate. Its meaning has changed. A comparison with no intervention answers a different question from a comparison with placebo, usual care or another credible intervention.
In our fictional trial, suppose both groups received the same recovery education, while only one received wearable-guided recommendations. If the wearable group improved meaningfully more, that strengthens the case that the wearable component contributed something beyond the education alone. It doesn’t establish that the programme is better than every other recovery option.
Editorial check: Compared with what—and is that comparison strong enough to support the claim you’re making?
The control group may look like a technical detail buried in the paper. It often determines what “effective” actually means.
6. Did the study find what it was looking for—or something interesting along the way?
Imagine our wearable trial measured sleep quality, HRV, resting heart rate, mood, stress, energy and recovery. HRV produced an exciting result. Before making it the headline, ask whether HRV was one of the outcomes researchers originally set out to test.
Studies usually identify a primary outcome and may specify secondary outcomes in advance. Ideally, these decisions are documented before researchers see the results. That matters because the more outcomes researchers examine, the greater the chance of finding at least one apparently significant result.
But there is an important distinction here. A pre-specified secondary outcome is not the same as an exploratory finding identified after examining the data. And an unexpected result isn’t automatically meaningless. It may raise an excellent question for future research. It simply shouldn’t be presented with more certainty than it deserves.
Suppose sleep quality was our study’s preregistered primary outcome, while the interesting HRV result emerged from an exploratory analysis. That makes “improves stress resilience” a much harder headline to defend.
Editorial check: Was this the question the study was designed to answer—or an interesting question the results raised afterward?
Both can make good stories. They are different stories.
7. Who funded the study—and does that change how you should read it?
You reach the disclosures and discover that the wearable manufacturer funded the trial. That matters. It doesn’t automatically make the research unreliable.
The more useful question is: What influence could the funder have had over the research?
Check who designed the study, whether the protocol was registered, who analysed the data, whether researchers had full access to it, whether the sponsor was involved in writing, and whether the scientists retained control over publication.
Suppose our trial was industry-funded, but its primary outcome was preregistered, relevant conflicts were disclosed and independent academic researchers retained control over analysis and publication.
Suppose our trial was industry-funded, but its primary outcome was preregistered, relevant conflicts were disclosed and independent academic researchers retained control over analysis and publication.
The appropriate response isn’t necessarily to discard the study. The funding relationship becomes one piece of context alongside the quality of the research. It is also worth checking whether independent researchers have found similar results.
Editorial check: Could the organization benefiting from the finding have influenced what was tested, how it was analysed or what ultimately got reported?
Skepticism is most useful when it leads to another question, not an automatic verdict.
8. Is this one exciting study—or part of a convincing body of evidence?
So far, we’ve evaluated this study. Now zoom out.
You don’t need to conduct a systematic review every time you cover a new paper. But you need enough of a search to know whether you’re looking at confirmation, contradiction or genuinely early evidence.
Look for previous trials and, where available, systematic reviews or meta-analyses. Has the result been replicated? Have independent teams found something similar? Is there substantial contradictory evidence?
Perhaps several previous trials found similar improvements in sleep quality. Our study strengthens an existing pattern. Perhaps previous research is mixed. The new result becomes an interesting contribution to an unresolved question. Or perhaps this is the first human trial. That can be newsworthy precisely because it is early—not because the question has been settled.
That’s why these phrases aren’t interchangeable:
“A new study suggests…”
“Several studies have found…”
“Research consistently shows…”
They communicate different levels of confidence.
Editorial check: If this study disappeared tomorrow, would the wider evidence still support your headline?
If not, you may still have a good story. You simply have a new finding, rather than an established conclusion.
Now let’s go back to our headline
We started with:
“New Study Shows Wearable Protocol Improves Stress Resilience and Recovery.”
After eight checks, we know more.
The trial is randomized and has a useful comparison group. Its primary sleep outcome was defined in advance, and the improvement in self-reported sleep quality appears meaningful enough to report.
But “stress resilience” wasn’t directly measured. The HRV result was exploratory. The participants were a relatively small, specific group. The study was industry-funded, although the relationship was transparent. And the wider evidence around HRV and recovery remains less certain.
So perhaps the more interesting headline is:
“A Wearable Recovery Programme Improved Sleep. Does That Mean It Improves Recovery?”
Now the evidence boundary itself creates the curiosity. And that’s an important distinction.
Research judgment isn’t about finding reasons not to publish. It’s about identifying what story the evidence has actually earned.
Sometimes, the evidence supports publishing confidently. Sometimes, an early finding deserves coverage with its limits visible. And sometimes, the research is sound but the original angle isn’t. In that case, changing the story is more useful than forcing the study into the headline you started with.
Good health content can simplify terminology, methodology and context. What it shouldn’t simplify away is the information that changes what the research means.
One final check catches a surprising number of problems:
Read the headline on its own. What would you think the study proved? Now check the paper: did it actually prove that?
If the headline introduces a broader outcome, population or level of certainty, revise it. When findings need to move across articles, newsletters, social content and commercial materials, keeping those distinctions intact becomes a system problem—not just a writing problem.
Research translation is part of the communication architecture I help health teams build at Sense-Maker Hub.
